Earnings Analyzer
Stock earnings page

West Pharmaceutical Services, Inc. (WST)

Track the next or latest earnings date for West Pharmaceutical Services, Inc., review consensus estimates, and see cached AI analysis for recent quarterly results.

Recent earnings news

West Pharmaceutical Services (WST) Stock Looks Overvalued Despite Upcoming Q2 Earnings
finance.yahoo.com · 3 days ago

West Pharmaceutical Services has delivered a strong 65.1% return over the past year, yet its valuation checks and current pricing suggest the stock is far from a clear bargain. Over the last 12 months, West Pharmaceutical Services shares are up 65.1%. This puts extra focus on whether recent ...

West Pharmaceutical Services Stock 10-Day Winning Spree: Stock Climbs 13% | Trefis
www.trefis.com · 4 days ago

West Pharmaceutical Services(WST) just hit a rare 10-day winning streak. Is this surge a buy signal or a trap? See what triggered it, and our valuation assessment.

MMSI or WST: Which Is the Better Value Stock Right Now?
finance.yahoo.com · 6 days ago

Investors with an interest in Medical ... (WST). But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look. The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our…

WST Stock Up Nearly 33% YTD: Will the Uptrend Continue in the Rest of 2026? - The Globe and Mail
www.theglobeandmail.com · 4 days ago

Shares of West Pharmaceutical Services Inc.WST have staged an impressive comeback in 2026, rising 32.9% year to date. The stock has outpaced the industry’s 30.3% decline and the S&P 500 Index’s 28.2% increase. The rebound reflects improving investor confidence following a strong first-quarter earnin…

West Pharmaceutical Services (WST) Is Up 6.7% After 21% Revenue Growth on Drug Delivery Demand - Simply Wall St News
simplywall.st · 6 days ago

West Pharmaceutical Services recently reported revenue growth of 21%, reflecting strong demand for its advanced containment and delivery systems for injectable drugs. This acceleration in sales underlines how the company’s proprietary and contract-manufactured products are increasingly central ...

Latest earnings date

Feb 12, 2026

Time not specified

Fiscal quarter: Dec/2025

EPS estimate: $1.83

Revenue estimate: N/A

Market cap: $17.91B

Analysis snapshot

No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.

Recent earnings history

Browse the calendar week
Date Quarter Report window EPS est. Revenue est.
Feb 12, 2026 Dec/2025 Time not specified $1.83 N/A